HUP0300689A3 - Method and compositions for treating an inflammatory disease - Google Patents

Method and compositions for treating an inflammatory disease

Info

Publication number
HUP0300689A3
HUP0300689A3 HU0300689A HUP0300689A HUP0300689A3 HU P0300689 A3 HUP0300689 A3 HU P0300689A3 HU 0300689 A HU0300689 A HU 0300689A HU P0300689 A HUP0300689 A HU P0300689A HU P0300689 A3 HUP0300689 A3 HU P0300689A3
Authority
HU
Hungary
Prior art keywords
compositions
treating
inflammatory disease
inflammatory
disease
Prior art date
Application number
HU0300689A
Other languages
Hungarian (hu)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HUP0300689A2 publication Critical patent/HUP0300689A2/en
Publication of HUP0300689A3 publication Critical patent/HUP0300689A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300689A 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease HUP0300689A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (2)

Publication Number Publication Date
HUP0300689A2 HUP0300689A2 (en) 2003-07-28
HUP0300689A3 true HUP0300689A3 (en) 2003-09-29

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300689A HUP0300689A3 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Country Status (16)

Country Link
EP (1) EP1253919A4 (en)
JP (1) JP2003522142A (en)
KR (1) KR20020073577A (en)
CN (1) CN1398181A (en)
AU (1) AU7205701A (en)
BR (1) BR0108087A (en)
CA (1) CA2398184A1 (en)
CZ (1) CZ20022682A3 (en)
HK (1) HK1051319A1 (en)
HU (1) HUP0300689A3 (en)
IL (1) IL150963A0 (en)
MX (1) MXPA02007688A (en)
NO (1) NO20023737L (en)
PL (1) PL356447A1 (en)
WO (1) WO2001058441A1 (en)
ZA (1) ZA200206252B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
EA008108B1 (en) * 2001-09-19 2007-04-27 Алтана Фарма Аг Combination of a nsaid and a pde-4 inhibitors
US20040259863A1 (en) * 2001-10-31 2004-12-23 Hans-Michael Eggenweiler Type 4 phosphodiesterase inhibitors and uses thereof
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
CA2753604A1 (en) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Drug combinations containing pde4-inhibitors and nsaids
EP2400961B1 (en) * 2009-02-27 2017-11-22 Boehringer Ingelheim International GmbH Medicine combinations containing pde4 inhibitors and nsaids
CN103097385B (en) 2010-07-14 2016-08-03 诺华股份有限公司 IP receptor stimulating agent heterocyclic compound
TW201335160A (en) 2012-01-13 2013-09-01 Novartis Ag IP receptor agonist heterocyclic compounds
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
NZ251092A (en) * 1992-04-02 1996-12-20 Smithkline Beecham Corp 4-cyano-cyclohexane derivatives; medicaments; used in treating asthma
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (en) * 1996-09-20 1998-10-30 NOVEL N-SUBSTITUTED CYCLIC AMINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
CA2398184A1 (en) 2001-08-16
CN1398181A (en) 2003-02-19
CZ20022682A3 (en) 2003-09-17
JP2003522142A (en) 2003-07-22
NO20023737L (en) 2002-09-27
HUP0300689A2 (en) 2003-07-28
NO20023737D0 (en) 2002-08-07
MXPA02007688A (en) 2002-12-13
WO2001058441A1 (en) 2001-08-16
AU7205701A (en) 2001-08-20
PL356447A1 (en) 2004-06-28
ZA200206252B (en) 2003-08-26
BR0108087A (en) 2002-10-29
KR20020073577A (en) 2002-09-27
EP1253919A4 (en) 2007-03-14
IL150963A0 (en) 2003-02-12
HK1051319A1 (en) 2003-08-01
EP1253919A1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
AP2006003708A0 (en) Methods and compositions for treating flavivirusesand pestiviruses
IL151781A0 (en) Methods and compositions for rna interference
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002219945A1 (en) Composition and method for treating snoring
EP1438062A4 (en) Methods and compositions for treating dermal lesions
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU6832101A (en) Composition and method
IL144517A0 (en) Compositions and methods for treating cataracts
AU5294100A (en) Method and compositions for treating the inflammatory response
AU4163402A (en) Composition and method
IL144188A0 (en) Compositions for treating inflammatory response
SG101494A1 (en) Exposure method
EP1443820A4 (en) Composition and method for treating graft-versus-host disease
EP1351647A4 (en) Compositions and methods for treating hyperpigmentation
EP1461047A4 (en) Compositions and methods for animal treatment
IL150963A0 (en) Method and compositions for treating an inflammatory disease
EP1450820A4 (en) Method for treating or preventing inflammatory diseases
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
IL149367A0 (en) Method and compositions for treating pulmonary diseases
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
EP1349548A4 (en) Methods and compositions for treating periodontal disease
EP1261331A4 (en) Method and compositions for treating fibrotic diseases
GB0123898D0 (en) Method for treating objects
GB0118883D0 (en) Method for treating objects
EP1253930A4 (en) Method and compositions for treating hepatocellular cancer

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees